Identifying the response of a cancer patient to a particular therapeutic agent is critical in drug discovery and will significantly facilitate the development of personalized medicine. The publicly available drug response profiles across cell lines provide an alternative way for predicting the response of cancer drugs. In this work, we propose a topology based dual-layer network (TDLN) model to predict drug response based on large-scale cell line experiments. With the Cancer Cell Line Encyclopedia (CCLE), Genomics of Drug Sensitivity in Cancer (GDSC) and Cancer Therapeutic Response Portal (CTRP) datasets as benchmark datasets, our proposed topology based dual-layer network model outperforms other existing popular approaches and identify some novel indications of known drugs for cancer.
Drug responses Large-scale data Dual-layer network model Novel indications
This is a preview of subscription content, log in to check access.
This work was partly supported by National Natural Science Foundation of China (61772368, 61572363, 91530321, 61602347) and Natural Science Foundation of Shanghai (17ZR1445600).
Costello, J.C., et al.: A community effort to assess and improve drug sensitivity prediction algorithms. Nat. Biotechnol. 32, 1202–1212 (2014)CrossRefGoogle Scholar
Mirnezami, R., et al.: Preparing for precision medicine. N. Engl. J. Med. 366, 489–491 (2012)CrossRefGoogle Scholar
Simon, R., Roychowdhury, S.: Implementing personalized cancer genomics in clinical trials. Nat. Rev. Drug Discov. 12, 358–369 (2013)CrossRefGoogle Scholar
Wistuba, I.I., et al.: Methodological and practical challenges for personalized cancer therapies. Nat. Rev. Clin. Oncol. 8, 135–141 (2011)CrossRefGoogle Scholar
Qin, G., Zhao, X.M.: A survey on computational approaches to identifying disease biomarkers based on molecular networks. J. Theoret. Biol. 362, 9–16 (2014)CrossRefGoogle Scholar
Zeng, T., et al.: Big-data-based edge biomarkers: study on dynamical drug sensitivity and resistance in individuals. Brief. Bioinform. 17, 576–592 (2016)CrossRefGoogle Scholar
Barretina, J., et al.: The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature 483, 603–607 (2012)CrossRefGoogle Scholar
Garnett, M.J., et al.: Systematic identification of genomic markers of drug sensitivity in cancer cells. Nature 483, 570–575 (2012)CrossRefGoogle Scholar
Rees, M.G., et al.: Correlating chemical sensitivity and basal gene expression reveals mechanism of action. Nat. Chem. Biol. 12, 109–116 (2016)CrossRefGoogle Scholar
Cui, J., et al.: An integrated transcriptomic and computational analysis for biomarker identification in gastric cancer. Nucleic Acids Res. 39, 1197–1207 (2011)CrossRefGoogle Scholar
Li, Z., et al.: Two-stage flux balance analysis of metabolic networks for drug target identification. BMC Syst. Biol. 5(Suppl 1), S11 (2011)MathSciNetCrossRefGoogle Scholar
Liu, X., et al.: Identifying disease genes and module biomarkers by differential interactions. J. Am. Med. Inf. Assoc. 19, 241–248 (2012)CrossRefGoogle Scholar
Menden, M.P., et al.: Machine learning prediction of cancer cell sensitivity to drugs based on genomic and chemical properties. PLoS ONE 8, e61318 (2013)CrossRefGoogle Scholar
Zeng, T., et al.: Prediction of dynamical drug sensitivity and resistance by module network rewiring-analysis based on transcriptional profiling. Drug Resist. Updat. 17, 64–76 (2014)CrossRefGoogle Scholar
Zhang, N., et al.: Predicting anticancer drug responses using a dual-layer integrated cell line-drug network model. PLoS Comput. Biol. 11, e1004498 (2015)CrossRefGoogle Scholar
Wang, Y., et al.: PubChem: a public information system for analyzing bioactivities of small molecules. Nucleic Acids Res. 37, W623–W633 (2009)CrossRefGoogle Scholar
Yap, C.W.: PaDEL-descriptor: an open source software to calculate molecular descriptors and fingerprints. J. Comput. Chem. 32, 1466–1474 (2011)CrossRefGoogle Scholar
Cheng, F., et al.: Prediction of drug-target interactions and drug repositioning via network-based inference. PLoS Comput. Biol. 8, e1002503 (2012)CrossRefGoogle Scholar